Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 59Gastrointestinal Stromal Tumors 22Neoplasms 18Breast Neoplasms 16Kidney Neoplasms 12Carcinoma, Non-Small-Cell Lung 11Carcinoma 7Colorectal Neoplasms 6Neoplasm Metastasis 5Stomach Neoplasms 4Neuroendocrine Tumors 4Kidney Diseases 4Gastrointestinal Neoplasms 4Clear-cell metastatic renal cell carcinoma 4Carcinoma, Hepatocellular 4Adenoma, Islet Cell 4Prostatic Neoplasms 3Urologic Neoplasms 2Urogenital Neoplasms 2Pancreatic Neoplasms 2Lung Neoplasms 2Financial Stress 2Urothelial Cancer 1Urologic Diseases 1Thyroid Neoplasms 1Somatostatinoma 1Solid Tumors 1Solid Tumor 1Primary hyperoxaluria type 2 1Patient Preference 1

Interventions

napabucasin 1irinotecan sucrosofate 1cixutumumab 1Taxes 1Sunitinib 1Paclitaxel 1Oxaliplatin 1Octreotide 1Melphalan 1Leucovorin 1Irinotecan 1Gemcitabine 1Fluorouracil 1Fentanyl 1Everolimus 1Albumin-Bound Paclitaxel 190Y-octreotide, DOTA-Tyr(3)- 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Carcinoma, Islet Cell × Sunitinib × Clear all
NCT00428597 2010-10-11

A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors

Pfizer

Phase 3 Terminated
171 enrolled 28 charts
Gastrointestinal

Pancreatic Neoplasms, Carcinoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡